Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 70 | 0 | 11 | 0 | €870.80 | €883.50 | 1.458% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 4 | 0 | €431.95 | €450.36 | 4.263% |
| Boston Scientific | 55 | 0 | 2 | 0 | €73.50 | €77.06 | 4.846% |
| Biogen Inc. | 51 | 2 | 3 | 0 | €185.05 | €284.87 | 53.942% |
| Insmed Inc. | 47 | 0 | 7 | 0 | €68.50 | €77.15 | 12.627% |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 3 | 0 | €1,067.0 | €1,091.9 | 2.336% |
| Alnylam Pharmace. | 46 | 1 | 3 | 1 | €236.10 | €271.50 | 14.995% |
| Neurocrine Bioscience | 44 | 0 | 6 | 0 | €112.55 | €149.47 | 32.805% |
| UnitedHealth Group Inc. | 43 | 1 | 2 | 0 | €541.10 | €547.91 | 1.259% |
| HCA Holdings Inc. | 42 | 0 | 4 | 0 | €357.10 | €359.19 | 0.585% |
| Johnson & Johnson | 40 | 1 | 3 | 0 | €152.00 | €186.77 | 22.872% |
| Intuitive Surgical Inc | 37 | 0 | 3 | 0 | €438.65 | €449.53 | 2.479% |
| AbbVie Inc. | 34 | 0 | 3 | 0 | €180.60 | €181.55 | 0.523% |
| Acadia Pharmaceuticals | 35 | 1 | 7 | 0 | €15.21 | €29.92 | 96.747% |
| Edwards Lifesciences Corp. | 32 | 1 | 1 | 0 | €62.23 | €83.40 | 34.026% |